282 related articles for article (PubMed ID: 22820736)
1. Methylation by Set9 modulates FoxO3 stability and transcriptional activity.
Calnan DR; Webb AE; White JL; Stowe TR; Goswami T; Shi X; Espejo A; Bedford MT; Gozani O; Gygi SP; Brunet A
Aging (Albany NY); 2012 Jul; 4(7):462-79. PubMed ID: 22820736
[TBL] [Abstract][Full Text] [Related]
2. Lysine methylation of FOXO3 regulates oxidative stress-induced neuronal cell death.
Xie Q; Hao Y; Tao L; Peng S; Rao C; Chen H; You H; Dong MQ; Yuan Z
EMBO Rep; 2012 Apr; 13(4):371-7. PubMed ID: 22402663
[TBL] [Abstract][Full Text] [Related]
3. The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor.
Greer EL; Oskoui PR; Banko MR; Maniar JM; Gygi MP; Gygi SP; Brunet A
J Biol Chem; 2007 Oct; 282(41):30107-19. PubMed ID: 17711846
[TBL] [Abstract][Full Text] [Related]
4. Methylation of FoxO3 regulates neuronal cell death.
Zhu WG
Acta Pharmacol Sin; 2012 May; 33(5):577. PubMed ID: 22555369
[No Abstract] [Full Text] [Related]
5. Set9, a novel histone H3 methyltransferase that facilitates transcription by precluding histone tail modifications required for heterochromatin formation.
Nishioka K; Chuikov S; Sarma K; Erdjument-Bromage H; Allis CD; Tempst P; Reinberg D
Genes Dev; 2002 Feb; 16(4):479-89. PubMed ID: 11850410
[TBL] [Abstract][Full Text] [Related]
6. Deacetylation of FOXO3 by SIRT1 or SIRT2 leads to Skp2-mediated FOXO3 ubiquitination and degradation.
Wang F; Chan CH; Chen K; Guan X; Lin HK; Tong Q
Oncogene; 2012 Mar; 31(12):1546-57. PubMed ID: 21841822
[TBL] [Abstract][Full Text] [Related]
7. Regulation of p53 activity through lysine methylation.
Chuikov S; Kurash JK; Wilson JR; Xiao B; Justin N; Ivanov GS; McKinney K; Tempst P; Prives C; Gamblin SJ; Barlev NA; Reinberg D
Nature; 2004 Nov; 432(7015):353-60. PubMed ID: 15525938
[TBL] [Abstract][Full Text] [Related]
8. Lysine methylation and functional modulation of androgen receptor by Set9 methyltransferase.
Ko S; Ahn J; Song CS; Kim S; Knapczyk-Stwora K; Chatterjee B
Mol Endocrinol; 2011 Mar; 25(3):433-44. PubMed ID: 21273441
[TBL] [Abstract][Full Text] [Related]
9. Methylation-mediated regulation of E2F1 in DNA damage-induced cell death.
Xie Q; Bai Y; Wu J; Sun Y; Wang Y; Zhang Y; Mei P; Yuan Z
J Recept Signal Transduct Res; 2011 Apr; 31(2):139-46. PubMed ID: 21320024
[TBL] [Abstract][Full Text] [Related]
10. Direct activation of forkhead box O3 by tumor suppressors p53 and p73 is disrupted during liver regeneration in mice.
Kurinna S; Stratton SA; Tsai WW; Akdemir KC; Gu W; Singh P; Goode T; Darlington GJ; Barton MC
Hepatology; 2010 Sep; 52(3):1023-32. PubMed ID: 20564353
[TBL] [Abstract][Full Text] [Related]
11. FOXO3 shares common targets with ASCL1 genome-wide and inhibits ASCL1-dependent neurogenesis.
Webb AE; Pollina EA; Vierbuchen T; Urbán N; Ucar D; Leeman DS; Martynoga B; Sewak M; Rando TA; Guillemot F; Wernig M; Brunet A
Cell Rep; 2013 Aug; 4(3):477-91. PubMed ID: 23891001
[TBL] [Abstract][Full Text] [Related]
12. Multiple lysine methylation of PCAF by Set9 methyltransferase.
Masatsugu T; Yamamoto K
Biochem Biophys Res Commun; 2009 Mar; 381(1):22-6. PubMed ID: 19351588
[TBL] [Abstract][Full Text] [Related]
13. FOXO3 selectively amplifies enhancer activity to establish target gene regulation.
Eijkelenboom A; Mokry M; Smits LM; Nieuwenhuis EE; Burgering BM
Cell Rep; 2013 Dec; 5(6):1664-78. PubMed ID: 24360957
[TBL] [Abstract][Full Text] [Related]
14. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase.
Brunet A; Sweeney LB; Sturgill JF; Chua KF; Greer PL; Lin Y; Tran H; Ross SE; Mostoslavsky R; Cohen HY; Hu LS; Cheng HL; Jedrychowski MP; Gygi SP; Sinclair DA; Alt FW; Greenberg ME
Science; 2004 Mar; 303(5666):2011-5. PubMed ID: 14976264
[TBL] [Abstract][Full Text] [Related]
15. The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor.
Renault VM; Thekkat PU; Hoang KL; White JL; Brady CA; Kenzelmann Broz D; Venturelli OS; Johnson TM; Oskoui PR; Xuan Z; Santo EE; Zhang MQ; Vogel H; Attardi LD; Brunet A
Oncogene; 2011 Jul; 30(29):3207-21. PubMed ID: 21423206
[TBL] [Abstract][Full Text] [Related]
16. Computational identification and modeling of crosstalk between phosphorylation, O-β-glycosylation and methylation of FoxO3 and implications for cancer therapeutics.
Butt AM; Feng D; Idrees M; Tong Y; Lu J
Int J Mol Sci; 2012; 13(3):2918-2938. PubMed ID: 22489133
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide analysis of FOXO3 mediated transcription regulation through RNA polymerase II profiling.
Eijkelenboom A; Mokry M; de Wit E; Smits LM; Polderman PE; van Triest MH; van Boxtel R; Schulze A; de Laat W; Cuppen E; Burgering BM
Mol Syst Biol; 2013; 9():638. PubMed ID: 23340844
[TBL] [Abstract][Full Text] [Related]
18. Methylation, a new epigenetic mark for protein stability.
Yang XD; Lamb A; Chen LF
Epigenetics; 2009 Oct; 4(7):429-33. PubMed ID: 19829087
[TBL] [Abstract][Full Text] [Related]
19. FOXO3 is a glucocorticoid receptor target and regulates LKB1 and its own expression based on cellular AMP levels via a positive autoregulatory loop.
Lützner N; Kalbacher H; Krones-Herzig A; Rösl F
PLoS One; 2012; 7(7):e42166. PubMed ID: 22848740
[TBL] [Abstract][Full Text] [Related]
20. Functional interplay between acetylation and methylation of the RelA subunit of NF-kappaB.
Yang XD; Tajkhorshid E; Chen LF
Mol Cell Biol; 2010 May; 30(9):2170-80. PubMed ID: 20160011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
